Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:296-301

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roks, A. J. M.
Right arrow Articles by van Gilst, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roks, A. J. M.
Right arrow Articles by van Gilst, W. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Hypertension - basic studies
Right arrow Other Vascular biology

(Hypertension. 1999;34:296-301.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Angiotensin-(1–7) Is a Modulator of the Human Renin-Angiotensin System

Anton J. M. Roks; Peter Paul van Geel; Yigal M. Pinto; Hendrik Buikema; Robert H. Henning; Dick de Zeeuw; Wiek H. van Gilst

From the Department of Clinical Pharmacology, University of Groningen (Netherlands).

Correspondence to A.J.M. Roks, Department of Clinical Pharmacology, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, Netherlands. E-mail a.j.m.roks{at}med.rug.nl

Abstract—The renin-angiotensin system is important for cardiovascular homeostasis. Currently, therapies for different cardiovascular diseases are based on inhibition of angiotensin-converting enzyme (ACE) or angiotensin II receptor blockade. Inhibition of ACE blocks metabolism of angiotensin-(1–7) to angiotensin-(1–5) and can lead to elevation of angiotensin-(1–7) levels in plasma and tissue. In animal models, angiotensin-(1–7) itself causes or enhances vasodilation and inhibits vascular contractions to angiotensin II. The function of angiotensin-(1–5) is unknown. We investigated whether angiotensin-(1–7) and angiotensin-(1–5) inhibit ACE or antagonize angiotensin-induced vasoconstrictions in humans. ACE activity in plasma and atrial tissue was inhibited by angiotensin-(1–7) up to 100%, with an IC50 of 3.0 and 4.0 µmol/L, respectively. In human internal mammary arteries, contractions induced by angiotensin I and II and the non–ACE-specific substrate [Pro11,D-Ala12]-angiotensin I were antagonized by angiotensin-(1–7) (10-5 mol/L) in a noncompetitive way, with a 60% inhibition of the maximal response to angiotensin II. Contractions to ACE-specific substrate [Pro10]-angiotensin I were also inhibited, an effect only partly accounted for by antagonism of angiotensin II. Angiotensin-(1–5) inhibited plasma ACE activity with a potency equal to that of angiotensin I but had no effect on arterial contractions. In conclusion, angiotensin-(1–7) blocks angiotensin II–induced vasoconstriction and inhibits ACE in human cardiovascular tissues. Angiotensin-(1–5) only inhibits ACE. These results show that angiotensin-(1–7) may be an important modulator of the human renin-angiotensin system.


Key Words: angiotensin-(1–7) • angiotensin-(1–5) • angiotensin I • angiotensin II • angiotensin-converting enzyme • chymase • arteries




This article has been cited by other articles:


Home page
HypertensionHome page
J. M. Stewart, A. J. Ocon, D. Clarke, I. Taneja, and M. S. Medow
Defects in Cutaneous Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Production in Postural Tachycardia Syndrome
Hypertension, May 1, 2009; 53(5): 767 - 774.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. D. Kluskens, S. A. Nelemans, R. Rink, L. de Vries, A. Meter-Arkema, Y. Wang, T. Walther, A. Kuipers, G. N. Moll, and M. Haas
Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 849 - 854.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. O. Sampaio, C. Henrique de Castro, R. A.S. Santos, E. L. Schiffrin, and R. M. Touyz
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Hypertension, December 1, 2007; 50(6): 1093 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Keidar, M. Kaplan, and A. Gamliel-Lazarovich
ACE2 of the heart: From angiotensin I to angiotensin (1-7)
Cardiovasc Res, February 1, 2007; 73(3): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Reyes-Engel, L. Morcillo, F. J. Aranda, M. Ruiz, M. J. Gaitan, A. Mayor-Olea, P. Aranda, and C. M. Ferrario
Influence of Gender and Genetic Variability on Plasma Angiotensin Peptides
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2): 92 - 97.
[Abstract] [PDF]


Home page
HypertensionHome page
M. K. Raizada and S. D. Sarkissian
Potential of Gene Therapy Strategy for the Treatment of Hypertension
Hypertension, January 1, 2006; 47(1): 6 - 9.
[Full Text] [PDF]


Home page
GutHome page
G Paizis, C Tikellis, M E Cooper, J M Schembri, R A Lew, A I Smith, T Shaw, F J Warner, A Zuilli, L M Burrell, et al.
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Gut, December 1, 2005; 54(12): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
E. A van der Wouden, R. H Henning, L. E Deelman, A. J. Roks, F. Boomsma, and D. de Zeeuw
Does Angiotensin (1-7) Contribute to the Antiproteinuric Effect of ACE-inhibitors?
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 96 - 101.
[Abstract] [PDF]


Home page
Exp PhysiolHome page
M. J. Katovich, J. L. Grobe, M. Huentelman, and M. K. Raizada
Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension
Exp Physiol, May 1, 2005; 90(3): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H.M. van Esch, B. Tom, V. Dive, W. W. Batenburg, D. Georgiadis, A. Yiotakis, J. M.G. van Gool, R. J.A. de Bruijn, R. de Vries, and A.H. J. Danser
Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I-Induced Vasoconstriction
Hypertension, January 1, 2005; 45(1): 120 - 125.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-C. Zhong, D.-Y. Huang, Y.-M. Yang, Y.-F. Li, G.-F. Liu, X.-H. Song, and K. Du
Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats
Hypertension, December 1, 2004; 44(6): 907 - 912.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
H. Rosas-Vargas, R. M. Coral-Vazquez, R. Tapia, J. L. Borja, R. A. Salas, and F. Salamanca
Glu298Asp Endothelial Nitric Oxide Synthase Polymorphism Is a Risk Factor for Erectile Dysfunction in the Mexican Mestizo Population
J Androl, September 1, 2004; 25(5): 728 - 732.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Stegbauer, V. Oberhauser, O. Vonend, and L. C. Rump
Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats
Cardiovasc Res, February 1, 2004; 61(2): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. S. Santos, A. C. S. e Silva, C. Maric, D. M. R. Silva, R. P. Machado, I. de Buhr, S. Heringer-Walther, S. V. B. Pinheiro, M. T. Lopes, M. Bader, et al.
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
PNAS, July 8, 2003; 100(14): 8258 - 8263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Schmaier
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
I. Haulica, W. Bild, C. N Mihaila, T. Ionita, C. P Boisteanu, and B. Neagu
Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 124 - 128.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. O. Sampaio, A. A. S. Nascimento, and R. A. S. Santos
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1985 - H1994.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Wiemer, L. W. Dobrucki, F. R. Louka, T. Malinski, and H. Heitsch
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1-7) on the Endothelium
Hypertension, December 1, 2002; 40(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. McMurray, A. P. Davie, A. E. Loot, A. J.M. Roks, R. H. Henning, W. H. van Gilst, R. A. Tio, A. J.H. Suurmeyer, and F. Boomsma
Angiotensin-(1-7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats * Response
Circulation, November 12, 2002; 106 (20): e147 - e147.
[Full Text] [PDF]


Home page
HypertensionHome page
I. Kucharewicz, R. Pawlak, T. Matys, D. Pawlak, and W. Buczko
Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Hypertension, November 1, 2002; 40(5): 774 - 779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. F. van Rodijnen, T. A. van Lambalgen, M. H. van Wijhe, G.-J. Tangelder, and P. M. ter Wee
Renal microvascular actions of angiotensin II fragments
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F86 - F92.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-C. Wei, C. M. Ferrario, K. B. Brosnihan, D. M. Farrell, W. E. Bradley, A. A. Jaffa, and L. J. Dell'Italia
Angiotensin Peptides Modulate Bradykinin Levels in the Interstitium of the Dog Heart in Vivo
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 324 - 329.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Souza dos Santos, K. T. Passaglio, J. B. Pesquero, M. Bader, and A. C. Simoes e Silva
Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
Hypertension, September 1, 2001; 38(3): 660 - 664.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Tom, R. de Vries, P. R. Saxena, and A.H. J. Danser
Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade
Hypertension, July 1, 2001; 38(1): 95 - 99.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Wilsdorf, J. V. Gainer, L. J. Murphey, D. E. Vaughan, and N. J. Brown
Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm
Hypertension, April 1, 2001; 37(4): 1136 - 1140.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. A. Clark, D. I. Diz, and E. A. Tallant
Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
Hypertension, April 1, 2001; 37(4): 1141 - 1146.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Heitsch, S. Brovkovych, T. Malinski, and G. Wiemer
Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells
Hypertension, January 1, 2001; 37(1): 72 - 76.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. J. Allred, D. I. Diz, C. M. Ferrario, and M. C. Chappell
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues
Am J Physiol Renal Physiol, November 1, 2000; 279(5): F841 - F850.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Loot, A. J.M. Roks, R. H. Henning, R. A. Tio, A. J.H. Suurmeijer, F. Boomsma, and W. H. van Gilst
Angiotensin-(1-7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Circulation, April 2, 2002; 105(13): 1548 - 1550.
[Abstract] [Full Text] [PDF]